Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00933088 · ClinicalTrials.gov registry record
Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer
A clinical trial, sponsored by NYU Langone Health.
- Terminated
- Registry status
- 43
- Enrollment target
NCT00933088 is a clinical trial that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 43 participants.
The verdict
NCT00933088 was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The aims of this study are to determine the differential coping strategies used by adolescent daughters whose mothers have breast cancer, and how this relates to the stress responses they exhibit.
Interventions
- OTHER questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00933088
The ClinicalTrials.gov registry entry for NCT00933088 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which questionnaires is the first listed.
NCT00933088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00933088 about?
NCT00933088 is a clinical study titled "Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer". The aims of this study are to determine the differential coping strategies used by adolescent daughters whose mothers have breast cancer, and how this relates to the stress responses they exhibit.
What is the current status of trial NCT00933088?
This trial is currently terminated. The enrollment target is 43 participants. The study started on 2008-06. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00933088?
The interventions under investigation include: questionnaires (OTHER).
Who is sponsoring clinical trial NCT00933088?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.